Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kenvue Inc.

Capitalization 33.52B 29.3B 26.47B 25.33B 46.06B 3,101B 47.88B 316B 125B 1,481B 126B 123B 5,350B P/E ratio 2026 *
18.7x
P/E ratio 2027 * 17x
Enterprise value 41.05B 35.88B 32.41B 31.01B 56.4B 3,796B 58.63B 387B 153B 1,814B 154B 151B 6,551B EV / Sales 2026 *
2.64x
EV / Sales 2027 * 2.54x
Free-Float
99.66%
Yield 2026 *
4.87%
Yield 2027 * 4.99%
1 day+0.58%
1 week-4.89%
Current month-8.53%
1 month-6.47%
3 months+1.63%
6 months-4.16%
Current year+1.39%
1 week 17.36
Extreme 17.36
18.14
1 month 17.36
Extreme 17.36
19.18
Current year 16.56
Extreme 16.555
19.18
1 year 14.02
Extreme 14.02
25.17
3 years 14.02
Extreme 14.02
27.8
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 59 2025-07-13
Director of Finance/CFO 57 2025-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 58 2023-05-07
Change 5d. change 1-year change 3-years change Capi.($)
+0.58%-4.89%-23.32% - 33.52B
+0.10%-1.94%-10.31%+6.22% 350B
+0.15%-2.04%-5.35%+6.36% 139B
+1.01%-5.04%-1.09%+21.82% 71.21B
+1.08%-2.95%-0.68%-10.23% 60.36B
+4.26%-5.22%+32.11%-62.89% 31.79B
-0.48%-6.73%-41.48%-29.81% 19.61B
+0.54%-0.76%-12.23%-6.51% 18.97B
-2.32%-7.94%+0.20%+13.28% 11.37B
-1.27%-5.24%-9.47%-13.10% 8.7B
Average +0.36%-4.28%-7.16%-8.32% 74.51B
Weighted average by Cap. +0.42%-2.84%-7.19%+1.87%

Financials

2026 *2027 *
Net sales 15.54B 13.59B 12.27B 11.74B 21.36B 1,438B 22.2B 147B 58.11B 687B 58.33B 57.09B 2,481B 15.95B 13.94B 12.59B 12.05B 21.91B 1,475B 22.78B 150B 59.62B 705B 59.85B 58.58B 2,545B
Net income 1.82B 1.59B 1.44B 1.37B 2.5B 168B 2.6B 17.16B 6.8B 80.35B 6.82B 6.68B 290B 2B 1.75B 1.58B 1.51B 2.74B 185B 2.85B 18.84B 7.46B 88.23B 7.49B 7.33B 319B
Net Debt 7.52B 6.57B 5.94B 5.68B 10.34B 696B 10.74B 70.96B 28.12B 332B 28.23B 27.63B 1,201B 7.01B 6.13B 5.54B 5.3B 9.63B 648B 10.01B 66.12B 26.2B 310B 26.3B 25.75B 1,119B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-03-13 17.49 $ +0.58% 19,221,925
26-03-12 17.39 $ -1.47% 26,381,010
26-03-11 17.65 $ -1.73% 19,059,671
26-03-10 17.96 $ -1.10% 30,105,464
26-03-09 18.16 $ -1.25% 29,336,888
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
17.49USD
Average target price
19.83USD
Spread / Average Target
+13.40%

Quarterly revenue - Rate of surprise